Intravenous maintenance aminophylline dosage in patients with asthma on regular oral theophylline

Area of Science:

• Pediatric Pulmonology
• Clinical Pharmacology

Background:

• Asthma management in children requires precise medication dosing.
• Aminophylline (theophylline) is a bronchodilator used for asthma.
• Current dosing guidelines may not be optimal for all pediatric patients.

Purpose of the Study:

• To evaluate the accuracy of calculating intravenous aminophylline infusion rates based on previous oral dosage in children with chronic asthma.
• To compare this novel method with standard body weight-based guidelines.
• To assess the impact of upper respiratory infections on aminophylline dosing and toxicity risk.

Main Methods:

• Retrospective analysis of pediatric patients with chronic asthma receiving intravenous aminophylline.
• Comparison of infusion rates calculated from oral dosage equivalence versus body weight-based recommendations.
• Assessment of theophylline toxicity events in relation to infusion rates and patient conditions.

Main Results:

• Intravenous aminophylline infusion rates calculated from equivalent oral dosages demonstrated considerable accuracy in pediatric asthma patients.
• This oral dosage-based method is anticipated to be more effective than traditional body weight-based guidelines.
• Reducing infusion rates in patients with upper respiratory infections is likely to decrease the incidence of theophylline toxicity.

Conclusions:

• Calculating intravenous aminophylline infusion rates from prior oral doses offers a potentially more effective and accurate approach for pediatric asthma management.
• Clinical vigilance and dose adjustment in the presence of upper respiratory infections are crucial for preventing theophylline toxicity in children.